A retrospective monocentric study with large active files of patients monitored for rheumatoid arthritis, spondyloarthritis and systemic lupus erythematosus with as main endpoint the morbimortality of Covid-19 in these patients (number of patients hospitalized in conventional units and/or in intensive care and/or deceased). The results will be compared with those of the general population based on the epidemiological data of Covid-19.
Other: questionnaire assesment
15-minute face-to-face questionnaire
Inclusion Criteria:
- Patients with rheumatoid arthritis on conventional synthetic DMARD (csDMARDs) +/-
biological DMARD (bDMARDs) or targeted synthetic DMARD (tsDMARDs) +/- corticosteroid
therapy meeting ACR/EULAR 2010 classification criteria
- Patients with spondylarthritison biological DMARD or targeted synthetic DMARD +/-
conventional synthetic DMARD +/- non-steroidal anti-inflammatory drugs meeting ASAS
classification criteria
- Patients with systemic lupus erythematosus on hydroxychloroquine +/- conventional
synthetic DMARD +/- corticosteroid therapy +/- biological DMARD meeting ACR/EULAR 2019
classification criteria
Exclusion Criteria:
-
Lille University Hospital
Lille, France
Jean-Guillaume Letarouilly, MD, Principal Investigator
University Hospital, Lille